“Ask yourself: If Ebola really was spread from person to person, instead of controlled spread through vaccination — then WHY would the CDC and the U.S. Government continue to allow flights in and out of these countries with absolutely no regulation, or at all?”
Quote Attributed to Nana Kwame, Accra, Ghana
In this article, I will endeavor to at least raise questions for further investigation. For simplicity I have made extensive use of endnotes. While mass forced inoculation of potentially dangerous vaccines and the imposition of martial law in the U.S. and NATO are certainly foreseeable long-term outcomes of the current situation, I will leave these for other commentators to speculate on. Also, while the “pandemic” is claimed by many to be a foil for strategic occupation of resource-rich African territory by the U.S./NATO, my treatment of troop deployments only relates to (a) the reality of the epidemic/pandemic and (b) the possibility that countermeasures have been developed to allow troops to operate in a contaminated environment or that this deployment is really a large-scale clinical trial of such Ebola countermeasures.
There is little doubt in my mind that the filovirus agents causing Ebola are real and that they are (or appear to be) making a sudden and unlikely spread after 94 or so years of relative inactivity.[i] However, many in Africa do not believe in the reality of Ebola or blame it on vaccination programs and foreign testing labs in their respective countries.[ii] Dr. Cyril E. Broderick, a Delaware State University (DSU) associate professor has made serious allegations concerning the development of recombinant Ebola-containing strains and their testing on African populations utilizing various labs and NGOs, and alleges experiments by the U.S. DoD.[iii] Reports have also surfaced in Liberia of water sources being poisoned with toxic substances to simulate Ebola symptoms as well as untested “Ebola vaccines” being administered to people with ill effects.[iv]
Is this pure superstition from “darkest Africa”? There have been numerous vaccination programs in the affected regions of Africa. (Some 100-million Africans were immunized against smallpox prior to 1972 when the disease was declared officially eradicated. Massive campaigns by NGOs and governmental agencies have increased numbers of vaccinated (all types) individuals in the Ebola-affected areas from less than 50% in 1990 to greater than 80% in 2010.[v] For varying historical reasons[vi] one could easily posit the existence of man-made live vaccinia smallpox vaccines incorporating key Ebola genes, potentially producing false test positives and Ebola-like symptoms, and covertly administered as part of existing vaccination programs.[vii]
[Please click below to continue reading]
This approach is certainly in the literature using other vectors—such as a vaccine based on the highly contagious virus causing the common cold. In August, GlaxoSmithKline’s (GSK) experimental Ebola vaccine was fast-tracked into human studies’. The GSK vaccine consists of adenovirus, engineered to carry two genes of the Ebola virus.[viii]
GSK expressed much optimism over these tests in a recent corporate press release[ix], highlighting work with Professor Samba Sow of the Center for Vaccine Development in Mali (a joint initiative between the University of Maryland School of Medicine and the Ministry of Health of Mali). These tests began in Bamako, Mali. (Malian sources allege that Mali’s first “Ebola” case on 24 October, a small child, had been out of the country previously, apparently to allay public fears over the vaccine trials. Nevertheless, on October 25th, Mauritania closed its border with Mali)
The most accurate test for Ebola, the PCR or polymerase chain reaction technique, makes millions of copies of single gene fragments. It is qualitative and cannot give indication of concentration. This is not only my opinion. The creator of the Cetus’ PCR technique, Kary Mullis, states:
“Quantitative PCR is an oxymoron. PCR is intended to identify substances qualitatively, but by its very nature is unsuited for estimating numbers. Although there is a common misimpression that the viral load tests actually count the number of viruses in the blood, these tests cannot detect free, infectious viruses at all…The tests can detect genetic sequences of viruses, but not viruses themselves.”[x], [xi]
The FilmArray automated screener, produced by a company called BioFire, Salt Lake City, UT, a subsidiary of France’s bioMérieux, should improve PCR testing at hospitals with its 1-hour result time. However, keep in mind that this is a PCR-based test. A person vaccinated with something like the GSK vaccine, for example, would test POSITIVE with this system. There would also be a similar number of false positives. (Also worth noting: the machine was in place in Texas where Ebola-casualty Duncan was turned away but FDA guidelines prohibited the hospital from using the machine to screen for Ebola.)[xii]
The only sure way to detect Ebola, in fact, is to culture the virus in mammalian cells and then examine the viruses under SEM (scanning electron microscope). How often is this done? Rarely. Most labs do not have the containment facilities, equipment or staff to do this. So, as laymen, how do we know with certainty that most of the deaths from and recoveries from “Ebola” were, in fact, from that disease? We don’t. And neither do most of the experts.
I have serious questions as to whether the Ebola outbreak is indeed a pandemic, about its non-exponential spread[xiii], the curious variance in symptomology (e.g., symptomology is extremely vague—could be almost anything[xiv] only 18% of cases exhibit the hemorrhagic characteristics that supposedly define the disease[xv]), the appalling lack of preparation of healthcare workers and emergency preparation despite tens of billions in U.S. agency expenditures for this purpose since 2002, lax quarantine and security procedures allowing infected and potentially infected individuals entry into the U.S. and contact with a large number of citizens[xvi], and the unrelenting harangue of the mass media creating panic in the population.
The recent televised transport of an ambulatory patient allegedly stricken with Ebola—accompanied by a shirt sleeved man toting a clipboard but no protective gear—who then walked up the steps of the waiting plane to be transported to a “clean” region, even managed to get the brief attention of the general public.[xvii]
We hear the 21-day quarantine figure bandied about and, after 21 days, the recovered parade around in public with no limitation. This seems strange as other filoviruses can be found in the bodily fluids for as long as 40 days after recovery. Prof. Charles Hass, Drexel Univ., states that when calculating the Ebola isolation period on the basis of past outbreaks, there is always a ‘standard deviation for results’—and that the 21-day period could be insufficient in 12% of patients.[xviii]
There also has been NO demonstration that it is impossible to be an asymptomatic carrier of the disease, yet officials behave as if this were the case, as pointed out by Dr. Jason Kissner, Associate Professor of Criminology at California State University:
“Furthermore, any scientist who is remotely competent will observe that asymptomatic transmission cannot possibly be completely ruled out regardless…simply because there can never be enough cases to statistically eliminate small probabilities of asymptomatic transmission. The only scientific question on this issue is whether such probabilities are so small that they can be considered negligible from a practical standpoint—and, right now, we don’t have a tremendous amount of cases at this point to base our conclusions on anyway.”[xix]
Even more strange, if this is a genuine pandemic: according to WHO, 42 days is necessary to be sure, i.e., twice the maximum incubation period for Ebola (21 days). WHO states: “…this 42-day period starts from the last day that any person in the country had contact with a confirmed or probable Ebola case.”[xx] So, if WHO thinks 42 days are necessary to be sure, why does the U.S. government assume survivors are completely clear of virus after recovery or only 21 days in quarantine?
To put it bluntly, it is highly suspicious that one of many similar African diseases—producing only a small fraction of the casualties of annual flu epidemics—is elevated to such a paramount status. Also, the disease has fallen far short of the 1-million infected figures projected months ago for present Africa. (All things being equal, these projections should have been accurate if this was a bona fide pandemic.) Instead we have major declines in some states and even complete eradication, as in Nigeria.[xxi]
A British journalist, James Ball, elaborates on this phenomena:
“…the spread of the disease has not been rapid in West Africa: around 400 new cases were reported in June, and a further 500 or so in July. This is a linear spread, meaning each person at present is infecting on average around (actually just over) one additional person. Far more worrying are diseases that spread exponentially: if one infected person spreads the disease to two or more on average, the illness spreads far quicker and is a much more worrying prospect, even if mortality is considerably lower. Since the Ebola outbreak began in February, around 300,000 people have died from malaria, while tuberculosis has likely claimed over 600,000 lives. Even Lassa fever, which shares many of the terrifying symptoms…kills many more than Ebola – and frequently finds its way to the US.”[xxii]
Agitating for designation of Ebola as a pandemic and advocating extreme measures and deeply involved in Ebola treatment and diagnosis in Africa, Doctors without Borders (founded as Médecins Sans Frontières (MSF) in 1971 by Bernard Kouchner and others) may be a “missing link” between the Ebola situation and the Neocon faction.
(Kouchner photographed below with G.W. Bush.)
I sometimes wonder if this organization—since it is deeply involved in many world trouble spots—e.g., opposing Serbs in Kosovo, supporting expanded Iranian sanctions, helping the “coalition of the willing” in Afghanistan, and “fighting Ebola” in Africa (a former MSF doctor now spreading panic in New York)—really intends (as indicated by its name) to eliminate national borders by any means.
On the eve of 911 this year, the U.S. leading foreign policy mouthpiece, Foreign Policy magazine, ran a piece calling for a “medical NATO” curiously reminiscent of MSF’s designs. This “medical NATO,” so to speak, would consist of a coalition of countries that would recruit special teams…(that) would be deployed upon the WHO’s declaration of a global health emergency. They would have the authority to directly provide treatment drugs and implement prevention measures without political interference from a country in which an outbreak was happening. (Emphasis mine.)[xxiii] This, of course, is the exact concept espoused by Kouchner, former student radical-turned- Neocon, who brought Sarkozy to the fore in France and helped substitute interventionism and the “right to intervene”[xxiv] for French nationalism.
The U.S. has already adopted this posture unilaterally by setting up a facility in Liberia (and presumably stationing troops at it) solely on the say so of USAID![xxv]
In the weeks before a major WHO press conference on Ebola on June 27th 2014, MSF became increasingly agitated, attempting to portray the Ebola situation as “out of control.” Some speculate the press conference was held to counteract this panic with spokesman Glenn Thomas (reportedly killed shortly after in the downing by Ukranian fighter jets of Malaysian Airlines flight MH17) presenting Ebola expert Pierre Formenty, who categorically denied that Ebola was “out of control,” as reporters and Doctors Without Borders suggested. (WHO’s own figures, cited elsewhere in this article, show Ebola is NOT progressing exponentially.)[xxvi]
Jumping ahead to recent events, Dr. Craig Allen Spencer, the Ebola doctor of New York, supposedly returned from his stint in Guinea with Borders/MSF “totally unaware” he was exposed but then went out on the town after “self reporting” himself, “hit the lanes in Williamsburg, visited Manhattan’s High Line park and used…the subway…to get around.”[xxvii]
What’s even more curious about the seemingly reckless behavior of this medical doctor is that, while he supposedly didn’t know he was exposed he followed the exact time pattern of the first Ebola casualty in the U.S., Thomas Duncan, who did know that he was exposed but was turned away from hospital.[xxviii]
PRE-911 GROUNDWORK FOR ‘BIOSHIELD’
Continuing and expanding the Bush-era “biodefense” Project BioShield, which now requires annual Congressional reappropriation, is being offered as the answer to this “crisis.” (Millions of deaths from malaria, TB and common influenza every year apparently do not rise to this level—for good reason—Ed.)
To understand the significance of expanded “biodefense” in perspective, it’s important to understand how biowarfare tests and countermeasures are developed . Obviously, countermeasure developers virtually never have access to bacteria or viruses developed by a potential enemy. So the biological threats first have to be created. In reality, there is no difference between defensive and offensive biological research—the results can be used for either purpose.
In the mid 1980s, as editor of BioEngineering News, I learned this firsthand with a 1000-page response from the U.S. Dept. of Defense to my FOIA request: a voluminous listing of toxic recombinant strains developed as countermeasures to an alleged offensive Soviet germ-warfare program (denied by Russia after the collapse of the USSR[xxix].) In order to develop tests and treatments for, say, an E. coli (gut bacteria) expressing genes coding for cobra venom, you first have to develop a simulacrum of the agent, i.e., you first have to produce the bioweapon. According to data in the DoD FOIA response, this was done.
The genesis of this early DoD “bioweapons defense” program can be found in the shadowy realm of proto-Neocons in the Reagan administration searching for a way to sidestep the 1972 BWC, possibly to put pressure on the USSR to allow massive immigration of purportedly persecuted Russian Jews to Israel and, if possibly, to hasten the defeat of the USSR.
The bridge between the early DoD program and the post-911 BioShield Program of G.W. Bush was provided by William Kucewicz, a former associate of William Kristol on The Public Interest, first in a 1983 piece for insiders “Beyond Yellow Rain” written for Council of Foreign Relations (CFR) flagship Foreign Affairs[xxx] and later in a widely-read popular series running in the Wall Street Journal between April and June 1984.[xxxi]
(It should be remembered that Kristol was co-author of the infamous PNAC document for Israel in 1997.)
Kucewicz’s articles were followed some 8 years later by the 1992 defection (from Russia, as the USSR had already collapsed) of former Soviet biowarfare scientist Kanatzhan (Kanat) Alibekov aka Ken Alibek—who later became consultant to the CIA, FBI and other U.S. Government agencies. (Alibek, who subsequently benefitted from G.W. Bush’s Project BioShield, is now Vice Chairman of AFG BioSolutions Inc., Gaithersburg, Md., and President and Chief Scientific Officer of MaxWell Biocorporation, LLC, incorporated in Newark, Del., but with main operations in Kiev, Ukraine and, in 2015, possible operations within Kazakhstan as well.)
(Due to the similarity of Alibek’s revelations, the projects in the 1980s DoD program, and the disclosures in Kucewicz’s 1980s WSJ articles, I suspect Alibek may have been a “mole” long before the fall of the USSR! If so, he was certainly looking far ahead.)
To the general public, Alibek is known for his pre-911 “tell all” in 2000 on the alleged Soviet offensive germ warfare program that supposedly included recombinant Ebola and Marburg strains: Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World–Told from Inside by the Man Who Ran It (ISBN 385334966/ISBN13: 9780385334969). First published in Jan. 1999 and republished by Delta on April 11, 2000, the book received rave reviews from the New York Times and Newsweek.
The book details claims of incurable and horrifying Ebola-related fevers, bubonic plague missile warheads and massive batches of recombinant anthrax, Ebola and smallpox. During this program, one of Alibekov’s associates (Ustinov) reportedly met his end in a bloody pool after becoming infected with a special virulent Marburg strain.
As an antidote to Ebola, Alibek is believed to have favored incorporating Ebola genes into conventional Vaccinia smallpox vaccines. You will recall the U.S. government (CDC) acquired significant smallpox vaccine stockpiles, including some 101-million doses beyond their expiration date: 15-million of doses of Dryvax vaccine made by Wyeth in the 1970s and 86-million doses of 40-year old Aventis vaccine, which may or may not have been refrigerated properly. Both of these vaccines were made from diseased calf lymph.[xxxii] (No doubt someone could make a great deal of money by modifying these old vaccines for Ebola treatment and, using existing laws, having the concoctions foisted on the public–Ed.)
Since G.W. Bush, all U.S. military have been required to get the smallpox vaccine and Bush launched a coercive effort to vaccinate all healthcare workers, which met with considerable resistance due to the inherently hazardous nature of smallpox vaccination.[xxxiii] The newer generation of smallpox vaccines, to be delivered by Acambis, PLC of Great Britain, are being created from a continuous cell line of MRC5 human fibroblast (fetal) tissue or Vero monkey-cell serum. Acambis is producing the vaccine in a joint venture with Baxter International[xxxiv].
(Smallpox is one of the most studied and understood agents in germ-warfare circles and it can be vaccinated against.[xxxv] It takes considerable exposure—up to 7 days of face-to-face contact—to contract and some theorize its primary means of transmission in the past may have been through bedbugs, as in the case of smallpox blankets to Indians. A vaccinia-Ebola construct would be even more easily handled as soldiers and medical workers would have some degree of immunity from the conventional smallpox vaccine.)
As U.S. troops deployed to Africa have received the smallpox vaccine but only minimal medical training, one is tempted to ask if it was a modified vaccine or if there is some reason for the U.S. Army to believe that a smallpox vaccination would confer immunity to Ebola?[xxxvi],[xxxvii]
AFTER 911…BIOWAR GOLD RUSH
Starting a year after the 911 destruction of the three WTC towers, G.W. Bush signed into law three enactments that, collectively, created a low-risk high-profit biowar gold rush for established and startup pharmaceutical and biotech companies:
- Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (P.L. 107-188)[xxxviii];
- Project BioShield Act of 2004 (P.L. 108-276)[xxxix]. When signed into law in 2004, BioShield initially provided over $7-billion to develop and warehouse millions of doses of new vaccines and drugs as “countermeasures” to biological weapons such as Ebola, plague, anthrax and smallpox[xl]; and,
- Pandemic and All-Hazards Preparedness Act of 2006 (P.L. 109-417)[xli]
In effect, these laws privatized what was, in effect, highly efficient biowarfare development under the umbrella of “countermeasures”. By 2006, contracting firms:
- Did not even have to deliver a finished product to get paid (previously a finished product was required for payment)
- Were exempt from disclosure of trade secrets and confidential information
- Did not have to comply with antitrust laws (the HHS Secretary can hold meetings and execute specific agreements with multiple potential countermeasure developers that would otherwise violate antitrust laws, contingent on prior approval of the Attorney General and the Chairman of the Federal Trade Commission—all part of the Executive Branch, i.e., the President is their boss.)
- All confidential, commercial, or proprietary corporate materials and data exempted from disclosure under FOIA
- Were exempted from FDA clinical trials and human testing of “countermeasures”
- Granted full liability protection for the vaccine manufacturers in the first pilot program to be sponsored by Bush under the legislation: the smallpox vaccination program.
- Project BioShield allowed the government to guarantee a market for specified amounts of particular countermeasures. Under this program, HHS could execute contracts at guaranteed prices even if delivery of the countermeasure has up to eight more years of development. (Originally, the government only paid for the countermeasure on delivery, but this provision was removed in 2006.)
- Simplified acquisition and micropurchase thresholds
- Expedited peer review
- Personal services contracts
- Bid competition limits
- Biomedical Advanced Research and Development Authority (BARDA) created to make advanced payments and milestone-based payments for Project BioShield contracts which do not have to be repaid even if the product is never delivered
- Make awards to foreign nationals (as in Africa, Ukraine, and Kazakhstan—Ed.)
- Guaranteed a market for “countermeasure” products in that these could be made mandatory under certain circumstances and at the sole discretion of the president or the secretary of health and human services.[xlii]
- HHS may specify in the acquisition contract that the vendor is the exclusive government supplier of the product for the duration of the contract, as long as the vendor can meet the government’s needs. The company cannot assign this exclusivity to another entity without the Secretary’s approval.
The 2006 law was, in addition, custom made for hiring not just domestic but foreign “specialists” (e.g., people like Ken Alibek) to scientific or professional positions or as special consultants for BARDA at the highest level of senior level pay for terms not to exceed five years. To fund BARDA activities it also established the “Biodefense Medical Countermeasure Development Fund” and appropriated $1.07-billion for FY2006 — FY2008 to remain available until expended. It also exempted technical and scientific data generated through BARDA ctivities from disclosure under the Freedom of Information Act (FOIA) if the data reveal significant and not otherwise publicly known vulnerabilities to CBRN threats.
MOTIVE, OPPORTUNITY, INTENT?
Law enforcement types like to refer to the elements of a crime as being: motive, opportunity and intent. A potential motivation for creating a false pandemic, as I see it, is the newly enacted annual appropriation requirement for Project BioShield in P.L. 113-5.
Up to the present, estimates of government largesse under this program range from $24- to nearly $50-billion. Reporting requirements for contractors were gutted in the post-911 panic. And labs and private entities benefitting from the program set up (or are setting up) operations offshore in places like Kazakhstan[xliii], Ukraine, and Africa. This Congress or the upcoming 114th Congress, whose term is January 3, 2015 to January 3, 2017, and the 115th Congress after that will now have to vote annually on this project. President Obama’s actions to date leave little doubt as to whether he would sign such a bill if it crossed his desk.
“In light of the nation’s difficult fiscal challenges, it would be easy to cut or eliminate federally funded government programs…In light of growing global instability and the diffusion of capabilities that offers states, disaffected groups and individuals with the means to conduct CBRN attacks, the national security partnership created by Project BioShield is a strategic hedge against an uncertain future,” maintains Robert Kadlec, of RPK Consulting, LLC, who was assistant to the president and senior director for Biodefense Policy during the George W. Bush Administration. [xliv]
Expansion of Project BioShield has clearly been put before Congress numerous times but, without a “Pearl Harbor type event” (to borrow a phrase from the 1997 PNAC document) it has made little headway. In 2012, for instance, the 112th Congress debated whether the BioShield acquisition mechanism merits extension based on its relative cost and contribution to national preparedness. They also considered changes to funding levels and how Congress provides BioShield funds.[xlv] In 2013 the current Congress passed The Pandemic and All-Hazards Preparedness Reauthorization Act (P.L. 113-5) authorizing BioShield appropriations of just $2.8-billion for FY2014 through FY2018.[xlvi]
From the standpoint of humanity in general, the current Ebola “pandemic” could not have come at a worse time. As “biodefense” research has dual use (it can be retooled into offensive weapons) a knee-jerk expansion of this program in 2015 could unilaterally gut the BWC (Biological Weapons Convention) of 1972, which bans the creation and stockpiling of biological weapons. Most major nations signed this treaty, which the U.S. Congress ratified and Gerald Ford signed into law in 1975. (I’m one of those skeptics who believe the alleged defensive nature of the bioweapons research coupled with privatization and offshoring, have already “gutted” the BWC much as Blackwater gutted the notion of nation-state armies and the rules of war.)
There have been calls for oversight of BioShield projects for compliance with BWC over the last decade—but these were largely ignored due to SARS, “Swine Flu,” “Bird Flu” and other convenient faux pandemics and the “threat of terror.”
From a gleam in the eye of proto-Neocons in the 1980s seeking to topple the USSR and/or force the USSR to “allow” Jewish emigration, the ending of the BWC seems to, once again, have become a centerpiece for the defeat or pressuring of countries seeking to establish a “multipolar” world. Like Israel’s “Sampson option” (and possibly the product of similar thinkers) the threat of a mass die off of humans and the destruction of civilization looms as a deterrent to those opposing the “Empire.”
About the author…
Tom Mysiewicz Graduated Magna cum laude from St. John’s Univ. (1976) on full science scholarship. Founded and edited the award-winning bioscience weekly newsletter BioEngineering News (ISSN 0275-4207–1980-1993). Also created and edited the Bio1000 World Directory of Biotechnology Companies (ISBN 0-936451-08-4). Created and edited DJM Enzyme Report, a monthly newsletter on enzyme science and technology, and World BioLicensing & Patent Report, a monthly covering patents and licenses in the bioscience field. After an 8-year hiatus, the events of 9-11 motivated him to cover the increasingly dangerous trend toward aggressive war and neoconservative dictatorship in the U.S. He predicted (in print) the exact start of the Iraq war months in advance and has made numerous correct predictions on unfolding events in the Mid East.
The statements, views and opinions expressed in this column are solely those of the author and do not necessarily represent those of Oceania Saker.
[i] Dr. Yves Le Ber, based in Brittany, has specialized on the issue of tropical fevers. In 1979 he spent several months in a hospital in Burkina Faso, where he studied Ebola first before publishing his thesis on the subject three years later. He finds evidence of the disease going back to 1920: “Ebola existed well before 1976 “, NetAfrique.Net, October 16th, 2014
[iii] Broderick notes that the DoD is listed as a collaborator in a “First in Human” Ebola clinical trial (NCT02041715, which started in January 2014 shortly before an Ebola epidemic was declared in West Africa in March. Disturbingly, he states, many reports also conclude that the US government has a viral fever bioterrorism research laboratory in Kenema, a town at the epicentre of the Ebola outbreak in West Africa.
“Ebola, AIDS Manufactured by Western Pharmaceuticals, US DoD?” Dr. Cyril Broderick, Professor of Plant Pathology, Liberian Observer, Tue, 09/09/2014: http://www.liberianobserver.com/security/ebola-aids-manufactured-western-pharmaceuticals-us-dod
[iv] A man in Schieffelin, a community located in Margibi County…has been arrested for attempting to put formaldehyde into a well used by the community…Mobbed by the community, he confessed that he had been paid to put formaldeyde into the well, and that he was not the only one. He reportedly told community dwellers, “We are many.” There are agents in Harbel, Dolostown, Cotton Tree and other communities around the country, he reportedly said. The man also alleged that some water companies, particularly those bagging mineral water to sell, are also involved. The poison, he said, produces Ebola-like symptoms…and subsequently kills people.
The (Liberian) Observer had previously been informed that people dressed as nurses were going into communities with ‘Ebola Vaccines’. [Emphasis mine.] Once injected, it reportedly produces Ebola-like symptoms and sends victims into a coma. Shortly thereafter, victims expire. Communities are now reportedly chasing vaccine peddlers out of their communities. After 10 children reportedly died from the ‘vaccine’ in Bensonville, the peddlers were reportedly chased out of the community upon their next visit.
Formaldeyde in Water Allegedly Causing Ebola-like Symptoms, Liberian Daily Observer, Sat, 08/02/2014: http://www.liberianobserver.com/security/breaking-formaldeyde-water-allegedly-causing-ebola-symptoms
[vi] Wayne Madsen, an analyst, sees significance in the 1976 emergence of Ebola during the Angola conflict: The same year that George H. W. Bush was the director of the CIA.”
“CIA should be probed for Ebola’s origin in Zaire,” Press TV, 19 October 2014, http://www.presstv.com/detail/2014/10/19/382847/cia-should-be-probed-for-ebola-origin/
[vii] According to the CDC, smallpox vaccine is made from live vaccinia virus and does not contain variola virus, the virus that causes smallpox. Vaccinia virus is a member of the orthopox virus family, which includes smallpox (variola), cowpox, monkeypox, gerbilpox, camelpox and others. When inoculated in the superficial layers of the skin, the virus grows and induces an immune reaction that serves to protect against smallpox. A successful vaccination is often referred to as a “take”. This take can include a number of symptoms, some of which can be treated with antihistamines. A smallpox vaccine containing Ebola genes could be expected to produce some of the symptoms seen in the current “epidemic” including the rapid recoveries of medical personnel (especially if previously inoculated against smallpox) and the seeming lack of fear by officials of virus shedding in recovered patients 21-40 days after recovery.
[viii] “GSK says Ebola vaccine development progressing at ‘unprecedented rate’,” Reuters U.S. Edition, 18 October 2014
[ix] Ebola vaccine trials fast-tracked by international consortium, 28 August 2014:
[xi] John Rappoport recently located more evidence of this: “Ebola Zaire (EZ1) rRT-PCR (TaqMan®) Assay on ABI 7500 Fast Dx, LightCycler, & JBAIDS: INSTRUCTION BOOKLET” published by “Joint Project Manager Medical Countermeasures Systems,” dated 14 August 2014. The device is manufactured by the Naval Medical Research Center for the US DoD and the manual includes the following caveat indicating the uncertainty in Ebola diagnosis: “…the EZ1 assay [the PCR test] should not be performed unless the individual has been exposed to or is at risk for exposure to Ebola Zaire virus or has signs and symptoms of infection with Ebola Zaire virus (detected in the West Africa outbreak in 2014) that meet clinical and epidemiologic criteria for testing suspect specimens.”
[xii] “Dallas Hospital Had the Ebola Screening Machine That the Military Is Using in Africa,” by Patrick Tucker, Defense One, 16 October 2014:
[xiii] Regions where massive numbers of new cases should be appearing report stability or reductions:
Nigeria and Senegal have contained Ebola and have been declared free of the disease: “Mauritania Closes Border With Mali Over Ebola Fears,” Deutsche Welle All Africa, 25 October 2014
15 October 2014 WHO stats show sharp drop in new cases in Liberia and Monrovia. Footnote indicates “probable” Ebola deaths—these are not confirmed and could be a way of inflating figures: http://apps.who.int/iris/bitstream/10665/136508/1/roadmapsitrep15Oct2014.pdf?ua=1
Ebola outbreak in Guinea, Liberia and Sierra Leone, Epicurve by week of onset, December 2013 to June 2014 (n=1257). As of 31 July
“Nimba County in Liberia—“Nimba Records Reduction in Ebola Cases,” Daily Observer, Monrovia, Liberia, 25 October 2014. http://www.liberianobserver.com/news/nimba-records-reduction-ebola-cases
[xiv] “The symptoms are extremely nonspecific in the beginning — Ebola looks like almost anything,” said Dr. Bruce Hirsch, an infectious-disease specialist at North Shore University Hospital in Manhasset, New York. A number of tests are used to confirm Ebola within a few days of the onset of symptoms, which can detect the virus’s genetic material or the presence of antibodies against the pathogen. (All of these tests would give a positive reading with Ebola-vaccinated individuals or if Ebola genes had been spliced into Vaccinia based on the genetic material or antibodies to Ebola, in the case of the ELISA test—Ed.)
“Ebola Virus: 5 Things You Should Know,” Tanya Lewis, livescience.com, http://www.livescience.com/21954-ebola-virus-outbreak-information.html
[xv] The official CDC Case Definition for Ebola Virus Disease (EVD) is a barn door open wide enough to fly a plane through: Clinical criteria, which includes fever of greater than 38.6 degrees Celsius or 101.5 degrees Fahrenheit, and additional symptoms such as severe headache, muscle pain, vomiting, diarrhea, abdominal pain, (i.e., all the symptoms of an ordinary flu—my emphasis) OR (my emphasis) unexplained hemorrhage; AND epidemiologic risk factors within the past 21 days before the onset of symptoms, such as contact with blood or other body fluids or human remains of a patient known to have or suspected to have EVD; residence in—or travel to—an area where EVD transmission is active; or direct handling of bats or non-human primates from disease-endemic areas.
[xvi] According to Paul Craig Roberts, “It’s now clear that the U.S. government has long known this outbreak was coming but did nothing to warn the public.” In other words, if the coming epidemic was real, explanation as to why no quarantines, warnings, travel restrictions, etc. were issued needs to be forthcoming. (Assuming government types are not suicidal, this explanation should include the reasons they did not feel personally threatened—Ed.) Roberts notes that, in early September, the government sought to purchase 160,000 Ebola hazmat suits from a U.S. supplier. http://www.naturalnews.com/046884_ebola_pandemic_hazmat_suits_biological_protection.html
Roberts additionally cites a report on SHTFplan.com, “Disaster Assistance Response Teams were told to prepare to be activated in the month of October.” http://www.shtfplan.com/headline-news/report-disaster-teams-were-told-months-ago-they-would-be-activated-in-october_10012014
[xvii] Two health staff escorting Amber Vinson did not have biosecurity level 4 personal ventilators. Also, a man carrying a clipboard and without any protective gear can be seen hovering close by: http://www.zerohedge.com/news/2014-10-16/idiotic-explanation-why-idiot-clipboard-was-unprotected
[xviii] “Ebola quarantine period is NOT long enough: Deadly virus could lay dormant in the body for longer than 21 days, expert claims,” Lizzie Parry, Daily Mail Online Published: 12:09 EST, 16 October 2014 | Updated: 13:31 EST, 16 October 2014
[xix] “Genetic Strains of Ebola that have Never been Seen Before: Media Lies and US Government Coverup,” Prof. Jason Kissner, Global Research, 6 October 2014
[xxi] The Ebola virus was introduced into Nigeria on 20 July 2014 when an infected Liberian man arrived by aeroplane into Lagos, Africa’s most populous city. The man, who died in hospital 5 days later, set off a chain of transmission that infected a total of 19 people, of whom 7 died. On October 20th, 2014, Nigeria reached that 42-day mark and is now considered free of Ebola transmission. http://www.who.int/mediacentre/news/ebola/20-october-2014/en/
[xxiii] The Ultimate Ebola-Fighting Force, by Jack C. Chow, Foreign Affairs, 10 September 2014 http://www.foreignpolicy.com/articles/2014/09/10/ebola_WHO_africa_epidemic_NATO
[xxiv] Talk of a “right to intervention” has naturally alarmed many people, especially those in the developing world who see it as another guise of the old imperialism. Let me assure those who accuse the emergent humanitarian army of acting on the basis that “might makes right…” Now it is necessary to take the further step of using the right to intervention as a preventive measure to stop wars before they start and to stop murderers before they kill…The charge of “human rights imperialism” against local cultural norms is also not a valid argument against the right to intervene. “Establish a Right to Intervene Against War, Oppression,” by Bernard Kouchner, L.A. Times, October 18th, 1999
[xxv] The Pentagon announced that it would set up a 25-bed field hospital in Liberia to help provide medical care for health workers responding to the epidemic. A Defense Department representative said the $22 million hospital is being provided at the request of USAID, which is coordinating the U.S. response. (Not the Liberian Govt.—Ed.)
“In Liberia, Ebola strengthens its hold,” by Brady Dennis, The Washington Post, Sept. 8th, 2014: http://www.washingtonpost.com/national/health-science/in-liberia-ebola-strengthens-its-hold/2014/09/08/916af094-3789-11e4-8601-97ba88884ffd_story.html
[xxvii] “Ebola-positive doctor Craig Spencer now quarantined in one of four special infectious disease rooms at Bellevue Hospital,” by Rocco Parascandola , Tina Moore , Corky Siemaszko, NEW YORK DAILY NEWS, October 23, 2014, 2:49 PM, Updated: Friday, October 24, 2014, 3:00 PM
[xxix] The official Moscow line, continuing from the Soviet era, is that Russia neither has nor had an offensive biological weapons development or procurement program. The existence of the Defense Ministry facilities is denied or explained in terms of “other than offensive” activities that represent an integral component of Russian national security. Russia’s current biological pathogen research also is described as entirely defensive or “peaceful” in nature. This according to Kenneth N. Luongo, Derek Averre, Raphael Della Ratta, and Maurizio Martellini at an arms control conference on the future of biothreat reduction they organized in Como, Italy in November 2003. (The authors note part of Russian intransigence on full transparency has been the refusal of the U.S. to allow inspection of its germ-warfare related centers—Ed.)
[xxx] “Yellow Rain” and the Future of Arms Agreements, Robert L. Bartley and William P. Kucewicz, Foreign Affairs, Council on Foreign Relations (CFR), Spring 1983 issue. http://www.foreignaffairs.com/articles/37404/robert-l-bartley-and-william-p-kucewicz/yellow-rain-and-the-future-of-arms-agreements
|[xxxi] Kucewicz, W. “Beyond ‘yellow rain:’ The threat of Soviet genetic engineering.” Wall Street Journal (series):Word From Behind the Iron Curtain, By WILLIAM KUCEWICZ; The Wall Street Journal; (Dec 28, 1984), p. 12;|
|When Arms Control Falls Short, By WILLIAM KUCEWICZ; The Wall Street Journal; (May 18, 1984), p. 26;|
|A Non-Stop Russian Response to WWI, By WILLIAM KUCEWICZ; The Wall Street Journal; (May 10, 1984), p. 34;|
|Lead Scientist in a Scourge Search, By WILLIAM KUCEWICZ; The Wall Street Journal; (May 1, 1984), p. 34;|
|Accident Prone and Asking for Calamity, By WILLIAM KUCEWICZ; The Wall Street Journal; (May 3, 1984), p. 28;|
|Surveying the Lethal Literature, By WILLIAM KUCEWICZ; The Wall Street Journal; (Apr 27, 1984), p. 28;|
|The Gates Slam Shut on a Microbiologist, By WILLIAM KUCEWICZ; The Wall Street Journal; (May 8, 1984), p. 34;|
|The Science of Snake Venom, By WILLIAM KUCEWICZ; The Wall Street Journal; (Apr 25, 1984), p. 30; and,|
|Soviets Search for Eerie New Weapons, By WILLIAM KUCEWICZ; The Wall Street Journal; (Apr 23, 1984), p. 30.|
[xxxiii] Reuters, December 12, 2001; ABC News, “A Worrisome Solution – Smallpox Report Sparks Mass Vaccination Concerns, ” November 5, 2002: “The American Medical Association said on Tuesday it was not in favor of an immediate mass U.S. smallpox vaccination program, saying the potential threat of bio-terror attack did not warrant inoculating every American against the disease;” “Doctor’s Group Votes to Oppose Vaccine Mandates,” November 2, 2000; Opposition to mass vaccination by American Academy of Pediatrics and the American Academy of Family Physicians is cited in: ABC News.com, “Smallpox Report Sparks Mass Vaccination Concerns, November 5, 2002.
[xxxiv]The Spectrum, Dr. Len Horowitz, “Smallpox and Anthrax Frights Planned Years Before 9-11 by Government and Drug Industry,” November 2002. p. 26. According to Horowitz, Acambis is owned by Aventis, whose parent company is Rhone-Poulenc. Both Rhone-Poulenc and Baxter were accused of having knowingly infected more than 7,000 American hemophiliacs with the AIDS virus during the 1980s and settled the class-action case for $100,000 per claimant.
[xxxv] Journal of the American Medical Association, Henderson DA, Inglesby et.al, June 9, 1999. “Smallpox as a Biological Weapon.” This article contains consensus statements of the Working Group on Civilian Biodefense.
[xxxvi] The website AnthraxWar.Com run by filmmaker/journalists Bob Coen and Eric Nadler questions Alibekov’s motives for relocating to Kiev in 2007 and establishing MaxWell Bio-Systems to develop and market “alternative cancer cures.” Many eyebrows were raised, according to the website, when it was learned that MaxWell’s President, Peter Leitner, previously headed a Republican task force on bio defense and was the President of the Higgins Counterterrorism Research Center and was also a Senior Fellow with the Center for Advanced Defense Studies. Heading up PR for Maxwell was Alex Meerovich, a veteran State Dept. operative with postings in Belarus, St. Petersberg, and Prague. George W. Bush’s Commerce Secretary Gutierrez (now working as Chairman of Madeline Albright’s Albright Stonebridge Group (ASG) a strategic advisory and commercial diplomacy firm) even jetted to Kiev to cut the ribbon in June 2008 at the grand opening of MaxWell’s $90-million state of the art production facility! http://www.anthraxwar.com/1/?p=497
[xxxvii] The AnthraxWar website also notes local suspicions about several Ukranian epidemics as possible germ-warfare tests as being by “foreign powers” including citizen reports of small, low flying planes spraying unknown substances. The largest such outbreak in 2009 infected some 1.4 million and killed nearly 200 with a bloody pneumonia first thought to be swine flu. According to the website, former Ukrainian President Yuschenko went on radio November 4th of that year to declare that “Infections of viral origin, including the A/H1N1 flu, are rapidly spreading across Ukraine…. Schools and universities were closed for three weeks and all mass gatherings, including campaign rallies heading into the January 17 presidential contest were banned. (One wonders if this was not a pre-Maidan effort to get rid of Yuschenko?—Ed.)
[xl] These drugs and vaccines are high-profit items as they are exempt from the regular approval process (which can cost upwards of $25-million for drugs, less for diagnostics and vaccines) and can be fast tracked to market with no human testing at all: “FDA acts to speed bioterror medicines,” by Marc Kaufman, Washington Post, May 31, 2002
[xlii]“The secretary shall specify in such [bioterror emergency] declaration the substance or substances that shall be considered covered countermeasures. . .” Homeland Security Act of 2002, Section 304(c)(p)(2)(A)(ii)
[xliii] Bakyt B. Atshabar will head the new lab, the Kazakh Scientific Center of Quarantine and Zoonotic Diseases, to be run for peaceful purposes. (Ebola and Marburg are booth Zoonotic—Ed.)
“Why the U.S. Is Building a High-Tech Bubonic Plague Lab in Kazakhstan,” Alex Pasternack, August 27, 2013 // 12:20 PM EST http://motherboard.vice.com/blog/why-the-us-is-building-a-high-tech-plague-lab-in-kazakhstan
[xliv] The Congress and the president recently took a very important step in perpetuating Project BioShield by passing and signing the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization, which authorizes an additional $2.8-billion for Project BioShield over the next five years. BioShield’s ultimate funding level, however, is now subject to the annual appropriations process. The question is this: will Congress will provide the funding?
“Now is not the time to falter on biodefense funding,” by Robert Kadlec, RPK Consulting, LLC. The Hill, April 17, 2013:
[xlv] The Project BioShield Act: Issues for the 112th Congress, by Frank Gottron, Specialist in Science and Technology Policy, 26 October 2012:
[xlvi] “The Project BioShield Act: Issues for the 113th Congress, “ by Frank Gottron
Specialist in Science and Technology Policy, 18 June 2014: